Publication | Open Access

Ascites predicts treatment benefit of bevacizumab in front-line therapy of advanced epithelial ovarian, fallopian tube and peritoneal cancers: An NRG Oncology/GOG study

Front-line TherapyMedicineCancer ManagementPathologyGynecologyFallopian TubeCancer TreatmentNrg Oncology/gog StudyOncologyRadiation OncologyGynecology OncologyOvarian Cancer